Hemodynamics in Chronic Kidney Disease
HORUZ
Improving the Hemodynamic Profile Of Chronic Renal Patients by Use of Bioimpedance
1 other identifier
observational
71
1 country
1
Brief Summary
The goal of this observational study is to learn about the role of thoracic and whole body bioimpedance in the hemodynamic profile of patients with chronic kidney disease. The main question it aims to answer is: \- Is bioimpedance-determined fluid status associated with kidney function decline in patients with chronic kidney disease stage 3 - 5 (non dialysis).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 9, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 9, 2022
CompletedFirst Submitted
Initial submission to the registry
March 21, 2025
CompletedFirst Posted
Study publicly available on registry
May 23, 2025
CompletedMay 23, 2025
January 1, 2021
1.2 years
March 21, 2025
May 20, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
whole body fluid status
The primary objective is to associate the bioimpedance-determined fluid status \[fluid overload versus non-fluid overload\] with kidney function decline in patients with chronic kidney disease stage 3 (59-30ml/min), 4 (29-15ml/min) and 5 (\< 15 ml/min).
Baseline, every 3 months during 1 year
Secondary Outcomes (1)
identify the clinical factors associated with fluid overload during a longitudinal follow up
Baseline, every 3 months during 1 year
Eligibility Criteria
206 patients with CKD stages 3-5 will be included from the outpatient clinic of Ziekenhuis Zuid-Oost Limburg in Genk (Belgium). A healthy control group for the cross-sectional part will be recruited through visitors and/or personnel of Ziekenhuis Oost-Limburg in Genk (Belgium).
You may qualify if:
- Prevalent non-dialysis patients with estimated glomerular filtration rate \< 60 ml/min (for chronic kidney disease subjects)
- Age \> 18 years
- Signed informed consent
You may not qualify if:
- Acute kidney injury
- estimated glomerular filtration rate \< 20ml/min directly post-nephrectomy
- Clinical conditions affecting bioimpedance measurements: limb amputation, impaired skin integrity, brain stimulator, pacemaker with low threshold or unipolar pacemaker.
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medicine and Life science
Hasselt, Belgium
Biospecimen
blood and urine
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pieter Vandervoort, PhD
University Hasselt
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 21, 2025
First Posted
May 23, 2025
Study Start
January 9, 2021
Primary Completion
March 9, 2022
Study Completion
March 9, 2022
Last Updated
May 23, 2025
Record last verified: 2021-01